Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial
- 17 June 2025
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 97, 16-27
Abstract
No abstract availableKeywords
Funding Information
- Universidade Federal do Rio Grande do Norte
- Usona Institute
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 38 references indexed in Scilit:
- Phenomenology of Psychedelic Experiences and Psychedelic-Associated Distressing Effects: Quantifying Subjective Experiences2024
- Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trialEuropean Neuropsychopharmacology, 2023
- LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy modelPsychological Medicine, 2021
- A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreatsPsychopharmacology, 2021
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trialPsychological Medicine, 2018
- Neuropharmacology of N,N-dimethyltryptamineBrain Research Bulletin, 2016
- Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogensHuman Psychopharmacology: Clinical and Experimental, 2016
- Human psychopharmacology of N,N-dimethyltryptamineBehavioural Brain Research, 1995
- Dose-Response Study of N,N-Dimethyltryptamine in HumansArchives of General Psychiatry, 1994
- The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamidePsychopharmacology, 1964